REAGAN MUSE: Open Payments
NPI 1407585607 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 34 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $457 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $141 |
| ABIOMED | 1 | $128 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $124 |
| Alnylam Pharmaceuticals Inc. | 8 | $121 |
| E.R. Squibb & Sons, L.L.C. | 6 | $108 |
| BridgeBio Pharma, Inc. | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| CVRx, Inc. | 1 | $21 |
| AtriCure, Inc. | 1 | $18 |
| VivaQuant Inc, dba Rhythm Express | 1 | $9 |
Products named: LEQVIO, JARDIANCE, AMVUTTRA, CAMZYOS, Attruby, EVKEEZA, Barostim Neo System, ATRICLIP LAA EXCLUSION SYSTEM.
Industry payments across AR — which companies pay providers there.
